RLY5016 is a high capacity cation binder for the treatment of hyperkalemia in chronic kidney disease patients. This compound is currently in Phase 1 clinical.

Hyperkalemia is an elevated blood level of the electrolyte potassium. Hyperkalemia may be the cause of medical emergencies and sometimes fatal heart rhythm abnormalities.

Important Hyperkalemia links:

Hyperkalemia disease description